The next board meeting for Biocryst Pharmaceuticals Inc. is on 04 Sep 2025 for the purpose of Cantor Global Healthcare ConferenceSee details
Biocryst Pharmaceuticals Inc. - BCRX - stock price prediction, stock price target, analyst ratings from 11 analysts
Biocryst Pharmaceuticals Inc. has a share price target of US$ 17, revenue growth forecast of 38.8%, and profit growth estimate of 123.6% for FY25, based on top 11 analyst calls.